Thioredoxin-1 gene therapy enhances angiogenic signaling and reduces ventricular remodeling in infarcted myocardium of diabetic rats.

Circulation

Volumn 121, Issue 10, 2010, Pages 1244-1255

  Samuel, Samson Mathews ^a   Thirunavukkarasu, Mahesh ^a   Penumathsa, Suresh Varma ^a   Koneru, Srikanth ^a   Zhan, Lijun ^a   Maulik, Gautam ^a   Sudhakaran, Perumana R ^a   Maulik, Nilanjana ^a  

^a UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEME OXYGENASE 1; MITOGEN ACTIVATED PROTEIN KINASE P38; STREPTOZOCIN; STRESS ACTIVATED PROTEIN KINASE; THIOREDOXIN; VASCULOTROPIN A;

ANGIOGENESIS; ANIMAL; APOPTOSIS; ARTICLE; CELL CULTURE; ENDOTHELIUM CELL; EXPERIMENTAL DIABETES MELLITUS; FIBROSIS; GENE THERAPY; GENETIC TRANSFECTION; GENETICS; HEART INFARCTION; HEART MUSCLE; HEART VENTRICLE REMODELING; HUMAN; MALE; METABOLISM; OXIDATIVE STRESS; PATHOLOGY; PATHOPHYSIOLOGY; RAT; SIGNAL TRANSDUCTION; SPRAGUE DAWLEY RAT;

ANIMALS; APOPTOSIS; CELLS, CULTURED; DIABETES MELLITUS, EXPERIMENTAL; ENDOTHELIAL CELLS; FIBROSIS; GENE THERAPY; HEME OXYGENASE-1; HUMANS; JNK MITOGEN-ACTIVATED PROTEIN KINASES; MALE; MYOCARDIAL INFARCTION; MYOCARDIUM; NEOVASCULARIZATION, PHYSIOLOGIC; OXIDATIVE STRESS; P38 MITOGEN-ACTIVATED PROTEIN KINASES; RATS; RATS, SPRAGUE-DAWLEY; SIGNAL TRANSDUCTION; STREPTOZOCIN; THIOREDOXINS; TRANSFECTION; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VENTRICULAR REMODELING;

EID: 77950496435     PISSN: None     EISSN: 15244539     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.109.872481     Document Type: Article

References (0)